Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

The RareCyte® platform for next-generation analysis of circulating tumor cells.

Kaldjian EP, Ramirez AB, Sun Y, Campton DE, Werbin JL, Varshavskaya P, Quarre S, George T, Madan A, Blau CA, Seubert R.

Cytometry A. 2018 Dec;93(12):1220-1225. doi: 10.1002/cyto.a.23619. Epub 2018 Oct 2.

PMID:
30277660
2.

Using DNase Hi-C techniques to map global and local three-dimensional genome architecture at high resolution.

Ma W, Ay F, Lee C, Gulsoy G, Deng X, Cook S, Hesson J, Cavanaugh C, Ware CB, Krumm A, Shendure J, Blau CA, Disteche CM, Noble WS, Duan Z.

Methods. 2018 Jun 1;142:59-73. doi: 10.1016/j.ymeth.2018.01.014. Epub 2018 Jan 31.

3.

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia.

Lee SI, Celik S, Logsdon BA, Lundberg SM, Martins TJ, Oehler VG, Estey EH, Miller CP, Chien S, Dai J, Saxena A, Blau CA, Becker PS.

Nat Commun. 2018 Jan 3;9(1):42. doi: 10.1038/s41467-017-02465-5.

4.

Comprehensive statistical inference of the clonal structure of cancer from multiple biopsies.

Liu J, Halloran JT, Bilmes JA, Daza RM, Lee C, Mahen EM, Prunkard D, Song C, Blau S, Dorschner MO, Gadi VK, Shendure J, Blau CA, Noble WS.

Sci Rep. 2017 Dec 5;7(1):16943. doi: 10.1038/s41598-017-16813-4.

5.

Human Cord Blood and Bone Marrow CD34+ Cells Generate Macrophages That Support Erythroid Islands.

Belay E, Hayes BJ, Blau CA, Torok-Storb B.

PLoS One. 2017 Jan 30;12(1):e0171096. doi: 10.1371/journal.pone.0171096. eCollection 2017.

6.

Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.

Kuderer NM, Burton KA, Blau S, Rose AL, Parker S, Lyman GH, Blau CA.

JAMA Oncol. 2017 Jul 1;3(7):996-998. doi: 10.1001/jamaoncol.2016.4983. No abstract available.

7.

Mapping 3D genome architecture through in situ DNase Hi-C.

Ramani V, Cusanovich DA, Hause RJ, Ma W, Qiu R, Deng X, Blau CA, Disteche CM, Noble WS, Shendure J, Duan Z.

Nat Protoc. 2016 Nov;11(11):2104-21. doi: 10.1038/nprot.2016.126. Epub 2016 Sep 29.

8.

A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer.

Blau CA, Ramirez AB, Blau S, Pritchard CC, Dorschner MO, Schmechel SC, Martins TJ, Mahen EM, Burton KA, Komashko VM, Radenbaugh AJ, Dougherty K, Thomas A, Miller CP, Annis J, Fromm JR, Song C, Chang E, Howard K, Austin S, Schmidt RA, Linenberger ML, Becker PS, Senecal FM, Mecham BH, Lee SI, Madan A, Ronen R, Dutkowski J, Heimfeld S, Wood BL, Stilwell JL, Kaldjian EP, Haussler D, Zhu J.

J Natl Compr Canc Netw. 2016 Jan;14(1):8-17.

9.

The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition.

Sperber H, Mathieu J, Wang Y, Ferreccio A, Hesson J, Xu Z, Fischer KA, Devi A, Detraux D, Gu H, Battle SL, Showalter M, Valensisi C, Bielas JH, Ericson NG, Margaretha L, Robitaille AM, Margineantu D, Fiehn O, Hockenbery D, Blau CA, Raftery D, Margolin AA, Hawkins RD, Moon RT, Ware CB, Ruohola-Baker H.

Nat Cell Biol. 2015 Dec;17(12):1523-35. doi: 10.1038/ncb3264. Epub 2015 Nov 16.

10.

Bipartite structure of the inactive mouse X chromosome.

Deng X, Ma W, Ramani V, Hill A, Yang F, Ay F, Berletch JB, Blau CA, Shendure J, Duan Z, Noble WS, Disteche CM.

Genome Biol. 2015 Aug 7;16:152. doi: 10.1186/s13059-015-0728-8.

11.

The Proteomic Landscape of Triple-Negative Breast Cancer.

Lawrence RT, Perez EM, Hernández D, Miller CP, Haas KM, Irie HY, Lee SI, Blau CA, Villén J.

Cell Rep. 2015 May 12;11(6):990. doi: 10.1016/j.celrep.2015.04.059. Epub 2015 May 12. No abstract available.

12.

High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining.

Campton DE, Ramirez AB, Nordberg JJ, Drovetto N, Clein AC, Varshavskaya P, Friemel BH, Quarre S, Breman A, Dorschner M, Blau S, Blau CA, Sabath DE, Stilwell JL, Kaldjian EP.

BMC Cancer. 2015 May 6;15:360. doi: 10.1186/s12885-015-1383-x.

13.

The proteomic landscape of triple-negative breast cancer.

Lawrence RT, Perez EM, Hernández D, Miller CP, Haas KM, Irie HY, Lee SI, Blau CA, Villén J.

Cell Rep. 2015 Apr 28;11(4):630-44. doi: 10.1016/j.celrep.2015.03.050. Epub 2015 Apr 16. Erratum in: Cell Rep. 2015 May 12;11(6):990.

14.

Sparse expression bases in cancer reveal tumor drivers.

Logsdon BA, Gentles AJ, Miller CP, Blau CA, Becker PS, Lee SI.

Nucleic Acids Res. 2015 Feb 18;43(3):1332-44. doi: 10.1093/nar/gku1290. Epub 2015 Jan 12.

15.

Fine-scale chromatin interaction maps reveal the cis-regulatory landscape of human lincRNA genes.

Ma W, Ay F, Lee C, Gulsoy G, Deng X, Cook S, Hesson J, Cavanaugh C, Ware CB, Krumm A, Shendure J, Blau CA, Disteche CM, Noble WS, Duan Z.

Nat Methods. 2015 Jan;12(1):71-8. doi: 10.1038/nmeth.3205. Epub 2014 Dec 1.

16.

A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor.

Belay E, Miller CP, Kortum AN, Torok-Storb B, Blau CA, Emery DW.

Blood. 2015 Feb 5;125(6):1025-33. doi: 10.1182/blood-2014-02-555318. Epub 2014 Oct 24.

17.

Inferring clonal composition from multiple sections of a breast cancer.

Zare H, Wang J, Hu A, Weber K, Smith J, Nickerson D, Song C, Witten D, Blau CA, Noble WS.

PLoS Comput Biol. 2014 Jul 10;10(7):e1003703. doi: 10.1371/journal.pcbi.1003703. eCollection 2014 Jul.

18.

JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.

Miller CP, Thorpe JD, Kortum AN, Coy CM, Cheng WY, Ou Yang TH, Anastassiou D, Beatty JD, Urban ND, Blau CA.

Cancer Immunol Res. 2014 Apr;2(4):301-6. doi: 10.1158/2326-6066.CIR-13-0189. Epub 2014 Jan 15.

19.

Derivation of naive human embryonic stem cells.

Ware CB, Nelson AM, Mecham B, Hesson J, Zhou W, Jonlin EC, Jimenez-Caliani AJ, Deng X, Cavanaugh C, Cook S, Tesar PJ, Okada J, Margaretha L, Sperber H, Choi M, Blau CA, Treuting PM, Hawkins RD, Cirulli V, Ruohola-Baker H.

Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4484-9. doi: 10.1073/pnas.1319738111. Epub 2014 Mar 12.

20.

Can we deconstruct cancer, one patient at a time?

Blau CA, Liakopoulou E.

Trends Genet. 2013 Jan;29(1):6-10. doi: 10.1016/j.tig.2012.09.004. Epub 2012 Oct 23.

22.

Can intensive longitudinal monitoring of individuals advance cancer research?

Blau CA.

Oncologist. 2012;17(5):587-9. doi: 10.1634/theoncologist.2012-0122. Epub 2012 Apr 20. No abstract available.

23.

HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition.

Zhou W, Choi M, Margineantu D, Margaretha L, Hesson J, Cavanaugh C, Blau CA, Horwitz MS, Hockenbery D, Ware C, Ruohola-Baker H.

EMBO J. 2012 May 2;31(9):2103-16. doi: 10.1038/emboj.2012.71. Epub 2012 Mar 23.

24.

Combination of Sleeping Beauty transposition and chemically induced dimerization selection for robust production of engineered cells.

Kacherovsky N, Harkey MA, Blau CA, Giachelli CM, Pun SH.

Nucleic Acids Res. 2012 Jun;40(11):e85. doi: 10.1093/nar/gks213. Epub 2012 Mar 8.

25.

Evaluating surface erythropoietin receptor in multiple myeloma.

Miller CP, Rattray K, Zhang Y, Wood BL, Burwick N, Chien S, Bensinger WI, Blau CA, Becker PS.

Leukemia. 2012 Aug;26(8):1883-6. doi: 10.1038/leu.2012.58. Epub 2012 Mar 1. No abstract available.

PMID:
22377897
26.

The structure and function of chromatin and chromosomes.

Noble WS, Blau CA, Dekker J, Duan ZJ, Mao Y.

Pac Symp Biocomput. 2012:434-40. No abstract available.

27.

Corrigendum to "Long-term Regulation of Genetically Modified Primary Hematopoietic Cells in Dogs".

Okazuka K, Beard BC, Emery DW, Schwarzwaelder K, Spector MR, Sale GE, von Kalle C, Torok-Storb B, Kiem HP, Blau CA.

Mol Ther. 2011 Nov;19(11):2102. doi: 10.1038/mt.2011.180. Epub 2016 Dec 6. No abstract available.

28.

HIF induces human embryonic stem cell markers in cancer cells.

Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CM, Hubaud A, Stadler B, Choi M, Bar M, Tewari M, Liu A, Vessella R, Rostomily R, Born D, Horwitz M, Ware C, Blau CA, Cleary MA, Rich JN, Ruohola-Baker H.

Cancer Res. 2011 Jul 1;71(13):4640-52. doi: 10.1158/0008-5472.CAN-10-3320. Epub 2011 Jun 28.

30.

Long-term regulation of genetically modified primary hematopoietic cells in dogs.

Okazuka K, Beard BC, Emery DW, Schwarzwaelder K, Spector MR, Sale GE, von Kalle C, Torok-Storb B, Kiem HP, Blau CA.

Mol Ther. 2011 Jul;19(7):1287-94. doi: 10.1038/mt.2011.8. Epub 2011 Feb 15. Erratum in: Mol Ther. 2011 Nov;19(11):2102. Torok-Storb, Beverly [added].

31.
32.

A three-dimensional model of the yeast genome.

Duan Z, Andronescu M, Schutz K, McIlwain S, Kim YJ, Lee C, Shendure J, Fields S, Blau CA, Noble WS.

Nature. 2010 May 20;465(7296):363-7. doi: 10.1038/nature08973. Epub 2010 May 2.

33.

Characterization of microRNAs involved in embryonic stem cell states.

Stadler B, Ivanovska I, Mehta K, Song S, Nelson A, Tan Y, Mathieu J, Darby C, Blau CA, Ware C, Peters G, Miller DG, Shen L, Cleary MA, Ruohola-Baker H.

Stem Cells Dev. 2010 Jul;19(7):935-50. doi: 10.1089/scd.2009.0426.

34.

Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.

Miller CP, Lowe KA, Valliant-Saunders K, Kaiser JF, Mattern D, Urban N, Henke M, Blau CA.

Stem Cells. 2009 Sep;27(9):2353-61. doi: 10.1002/stem.156.

35.

Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.

Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B, Lim R, Tewari M, Gartler SM, Issa JP, Pavlidis P, Duan Z, Blau CA.

Cell Stem Cell. 2009 Apr 3;4(4):359-69. doi: 10.1016/j.stem.2009.03.001.

36.

Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited.

Lin EH, Jiang Y, Deng Y, Lapsiwala R, Lin T, Blau CA.

Gastrointest Cancer Res. 2008 Jul;2(4):169-74.

37.

Using gene transfer to circumvent off-target effects.

Miller CP, Blau CA.

Gene Ther. 2008 May;15(10):759-64. doi: 10.1038/gt.2008.43. Epub 2008 Mar 20. Review.

PMID:
18356813
38.

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M.

JAMA. 2008 Feb 27;299(8):914-24. doi: 10.1001/jama.299.8.914. Review.

PMID:
18314434
39.

Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling.

Wang L, Schulz TC, Sherrer ES, Dauphin DS, Shin S, Nelson AM, Ware CB, Zhan M, Song CZ, Chen X, Brimble SN, McLean A, Galeano MJ, Uhl EW, D'Amour KA, Chesnut JD, Rao MS, Blau CA, Robins AJ.

Blood. 2007 Dec 1;110(12):4111-9. Epub 2007 Aug 29.

40.

Multiarm high-throughput integration site detection: limitations of LAM-PCR technology and optimization for clonal analysis.

Harkey MA, Kaul R, Jacobs MA, Kurre P, Bovee D, Levy R, Blau CA.

Stem Cells Dev. 2007 Jun;16(3):381-92.

PMID:
17610368
41.

Erythropoietin in cancer: presumption of innocence?

Blau CA.

Stem Cells. 2007 Aug;25(8):2094-7. Epub 2007 Apr 26. Review.

43.

A comparison of NIH-approved human ESC lines.

Ware CB, Nelson AM, Blau CA.

Stem Cells. 2006 Dec;24(12):2677-84. Epub 2006 Aug 17.

44.

Growth factor receptors as regulators of hematopoiesis.

Weinreich MA, Lintmaer I, Wang L, Liggitt HD, Harkey MA, Blau CA.

Blood. 2006 Dec 1;108(12):3713-21. Epub 2006 Aug 10.

45.

Anatomical compartments modify the response of human hematopoietic cells to a mitogenic signal.

Nagasawa Y, Wood BL, Wang L, Lintmaer I, Guo W, Papayannopoulou T, Harkey MA, Nourigat C, Blau CA.

Stem Cells. 2006 Apr;24(4):908-17. Epub 2005 Dec 22.

46.

Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation.

Gandhi MJ, Pendergrass TW, Cummings CC, Ihara K, Blau CA, Drachman JG.

Exp Hematol. 2005 Oct;33(10):1215-21.

PMID:
16219544
47.
48.

Collection of blood stem cells from patients with sickle cell anemia.

Richard RE, Siritanaratkul N, Jonlin E, Skarpidi E, Heimfeld S, Blau CA.

Blood Cells Mol Dis. 2005 Nov-Dec;35(3):384-8. Epub 2005 Aug 26.

PMID:
16125985
49.

Controlled-rate freezing of human ES cells.

Ware CB, Nelson AM, Blau CA.

Biotechniques. 2005 Jun;38(6):879-80, 882-3.

50.

Selection with a regulated cell growth switch increases the likelihood of expression for a linked gamma-globin gene.

Emery DW, Tubb J, Nishino Y, Nishino T, Otto KG, Stamatoyannopoulos G, Blau CA.

Blood Cells Mol Dis. 2005 May-Jun;34(3):235-47.

PMID:
15885608

Supplemental Content

Support Center